Riverview Trust Company’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,494
| Closed | -$167K | – | 360 |
|
|
2025
Q1 | $167K | Sell |
1,494
-25
| -2% | -$2.8K | 0.17% | 110 |
|
|
2024
Q4 | $140K | Hold |
1,519
| – | – | 0.13% | 125 |
|
|
2024
Q3 | $127K | Buy |
1,519
+25
| +2% | +$2.1K | 0.11% | 139 |
|
|
2024
Q2 | $103K | Sell |
1,494
-1,830
| -55% | -$126K | 0.1% | 153 |
|
|
2024
Q1 | $243K | Hold |
3,324
| – | – | 0.19% | 82 |
|
|
2023
Q4 | $269K | Hold |
3,324
| – | – | 0.27% | 80 |
|
|
2023
Q3 | $249K | Hold |
3,324
| – | – | 0.22% | 77 |
|
|
2023
Q2 | $256K | Hold |
3,324
| – | – | 0.23% | 70 |
|
|
2023
Q1 | $276K | Hold |
3,324
| – | – | 0.25% | 68 |
|
|
2022
Q4 | $285K | Hold |
3,324
| – | – | 0.27% | 65 |
|
|
2022
Q3 | $205K | Buy |
3,324
+482
| +17% | +$29.7K | 0.2% | 86 |
|
|
2022
Q2 | $176K | Hold |
2,842
| – | – | 0.15% | 106 |
|
|
2022
Q1 | $169K | Buy |
2,842
+1,012
| +55% | +$60.2K | 0.13% | 107 |
|
|
2021
Q4 | $133 | Hold |
1,830
| – | – | 0.08% | 104 |
|
|
2021
Q3 | $128K | Hold |
1,830
| – | – | 0.14% | 105 |
|
|
2021
Q2 | $126K | Hold |
1,830
| – | – | 0.13% | 105 |
|
|
2021
Q1 | $118K | Hold |
1,830
| – | – | 0.13% | 107 |
|
|
2020
Q4 | $107K | Hold |
1,830
| – | – | 0.12% | 112 |
|
|
2020
Q3 | $116K | Hold |
1,830
| – | – | 0.13% | 102 |
|
|
2020
Q2 | $141K | Hold |
1,830
| – | – | 0.14% | 105 |
|
|
2020
Q1 | $137K | Hold |
1,830
| – | – | 0.13% | 101 |
|
|
2019
Q4 | $119K | Hold |
1,830
| – | – | 0.08% | 133 |
|
|
2019
Q3 | $116K | Hold |
1,830
| – | – | 0.08% | 129 |
|
|
2019
Q2 | $124K | Hold |
1,830
| – | – | 0.09% | 122 |
|
|
2019
Q1 | $119K | Hold |
1,830
| – | – | 0.09% | 121 |
|
|
2018
Q4 | $114K | Buy |
+1,830
| New | +$114K | 0.09% | 114 |
|